Daniel Oertli
Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
Langer I, Burger D, Infanger E, Uehlinger U, Wight E, Schnarwyler B, Bronz L, Oertli D, Hess T, Fehr M, Schaer G, Koechli O, Berclaz G, Gueller U, Zuber M. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245:452-61.
Mar 1, 2007Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
Mar 1, 2007Ann Surg 2007; 245:452-61
Langer Igor, Burger Daniel, Infanger Eduard, Uehlinger Urs, Wight Edward, Schnarwyler Beate, Bronz Lucio, Oertli Daniel, Hess Thomas, Fehr Mathias K, Schaer Gabriel, Koechli Ossi R, Berclaz Gilles, Gueller Ulrich, Zuber Markus
Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients
Viehl C, Gueller U, Hamel C, Riehle H, Plaass C, Marti W, Oertli D, Zuber M. Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients. World J Surg 2006; 30:453-6.
Mar 1, 2006Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients
Mar 1, 2006World J Surg 2006; 30:453-6
Viehl Carsten T, Gueller Ulrich, Hamel Christian T, Riehle Hans-Martin, Plaass Christian, Marti Walter R, Oertli Daniel, Zuber Markus
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Adamina M, Oertli D, Spagnoli G, Amacker M, Zurbriggen R, Feder C, Groeper C, Rosenthal R, Weber W, Zajac P, Schumacher R, Heberer M. Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy. J Liposome Res 2006; 16:195-204.
Jan 1, 2006Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy
Jan 1, 2006J Liposome Res 2006; 16:195-204
Adamina Michel, Oertli Daniel, Spagnoli Giulio C, Amacker Mario, Zurbriggen Rinaldo, Feder Chantal, Groeper Célia, Rosenthal Rachel, Weber Walter P, Zajac Paul, Schumacher Reto, Heberer Michael
Detecting pheochromocytoma: defining the most sensitive test
Gueller U, Turek J, Eubanks S, Delong E, Oertli D, Feldman J. Detecting pheochromocytoma: defining the most sensitive test. Ann Surg 2006; 243:102-7.
Jan 1, 2006Detecting pheochromocytoma: defining the most sensitive test
Jan 1, 2006Ann Surg 2006; 243:102-7
Gueller Ulrich, Turek Joe, Eubanks Steve, Delong Elizabeth R, Oertli Daniel, Feldman Jerome M
High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients
Gueller U, Safford S, Pietrobon R, Heberer M, Oertli D, Jain N. High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 2005; 29:994-9; discussion 999-1000.
Aug 1, 2005High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients
Aug 1, 2005World J Surg 2005; 29:994-9; discussion 999-1000
Gueller Ulrich, Safford Shawn, Pietrobon Ricardo, Heberer Michael, Oertli Daniel, Jain Nitin B
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
von Holzen U, Heberer M, Oertli D, Marti W, Schumacher R, Feder C, Reschner A, Groeper C, Zajac P, Weber W, Bolli M, Adamina M, Spagnoli G. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy. Int J Cancer 2005; 115:248-55.
Jun 10, 2005Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy
Jun 10, 2005Int J Cancer 2005; 115:248-55
von Holzen Urs, Heberer Michael, Oertli Daniel, Marti Walter, Schumacher Reto, Feder Chantal, Reschner Anca, Groeper Célia, Zajac Paul, Weber Walter P, Bolli Martin, Adamina Michel, Spagnoli Giulio C
Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Spagnoli G, Adamina M, Bolli M, Weber W, Zajac P, Marti W, Oertli D, Heberer M, Harder F. Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation. World J Surg 2005; 29:692-9.
Jun 1, 2005Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation
Jun 1, 2005World J Surg 2005; 29:692-9
Spagnoli Giulio C, Adamina Michel, Bolli Martin, Weber Walter P, Zajac Paul, Marti Walter, Oertli Daniel, Heberer Michael, Harder Felix
Sample size matters: a guide for surgeons
Gueller U, Oertli D. Sample size matters: a guide for surgeons. World J Surg 2005; 29:601-5.
May 1, 2005Sample size matters: a guide for surgeons
May 1, 2005World J Surg 2005; 29:601-5
Gueller Ulrich, Oertli Daniel
Antigen specific active immunotherapy: lessons from the first decade
Adamina M, Oertli D. Antigen specific active immunotherapy: lessons from the first decade. Swiss Med Wkly 2005; 135:212-21.
Apr 16, 2005Antigen specific active immunotherapy: lessons from the first decade
Apr 16, 2005Swiss Med Wkly 2005; 135:212-21
Adamina Michel, Oertli Daniel
Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy
Langer I, Marti W, Gueller U, Moch H, Harder F, Oertli D, Zuber M. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241:152-8.
Jan 1, 2005Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy
Jan 1, 2005Ann Surg 2005; 241:152-8
Langer Igor, Marti Walter Richard, Gueller Ulrich, Moch Holger, Harder Felix, Oertli Daniel, Zuber Markus
Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients
Gueller U, Jain N, Curtis L, Oertli D, Heberer M, Pietrobon R. Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients. J Am Coll Surg 2004; 199:567-75; discussion 575-7.
Oct 1, 2004Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients
Oct 1, 2004J Am Coll Surg 2004; 199:567-75; discussion 575-7
Gueller Ulrich, Jain Nitin, Curtis Lesley H, Oertli Daniel, Heberer Michael, Pietrobon Ricardo
Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer
Gueller U, Heberer M, Harder F, Metzger U, Maurer R, Oertli D, Spagnoli G, Zuber M, Vorburger S, Bösch B, Schnider A, Zajac P, Marti W. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002; 236:768-75; discussion 775-6.
Dec 1, 2002Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer
Dec 1, 2002Ann Surg 2002; 236:768-75; discussion 775-6
Gueller Ulrich, Heberer Michael, Harder Felix, Metzger Urs, Maurer Robert, Oertli Daniel, Spagnoli Giulio Cesare, Zuber Markus, Vorburger Stefan, Bösch Beatrix, Schnider Annelies, Zajac Paul, Marti Walter Richard
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Oertli D, Heberer M, Harder F, Schumacher R, Adamina M, Padovan E, Kocher T, Noppen C, Zajac P, Marti W, Spagnoli G. Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo. Hum Gene Ther 2002; 13:569-75.
Mar 1, 2002Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo
Mar 1, 2002Hum Gene Ther 2002; 13:569-75
Oertli Daniel, Heberer Michael, Harder Felix, Schumacher Reto, Adamina Michel, Padovan Elisabetta, Kocher Thomas, Noppen Christoph, Zajac Paul, Marti Walter R, Spagnoli Giulio C
Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Spagnoli G, Zajac P, Marti W, Oertli D, Padovan E, Noppen C, Kocher T, Adamina M, Heberer M. Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy. Recent Results Cancer Res 2002; 160:195-201.
Jan 1, 2002Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy
Jan 1, 2002Recent Results Cancer Res 2002; 160:195-201
Spagnoli Giulio C, Zajac Paul, Marti Walter R, Oertli Daniel, Padovan Elisabetta, Noppen Christoph, Kocher Thomas, Adamina Michel, Heberer Michael
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Gueller U, Harder F, Oertli D, Marti W, Langer I, Moch H, Torhorst J, Viehl C, Schirp U, Nitzsche E, Zuber M. Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!. Breast Cancer Res Treat 2002; 71:171-3.
Jan 1, 2002Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Jan 1, 2002Breast Cancer Res Treat 2002; 71:171-3
Gueller Ulrich, Harder Felix, Oertli Daniel, Marti Walter R, Langer Igor, Moch Holger, Torhorst Joachim, Viehl Carsten T, Schirp Udo, Nitzsche Egbert U, Zuber Markus